830
Views
20
CrossRef citations to date
0
Altmetric
Clinical Study

A Prospective Study of Hepatitis B Vaccination – A Comparison of Responders versus Nonresponders

, , , , , & show all
Pages 276-279 | Received 25 Aug 2010, Accepted 27 Jan 2011, Published online: 14 Mar 2011

REFERENCES

  • Wong PN, Fung TT, Mak SK, Hepatitis B virus infection in dialysis patients. J Gastroenterol Hepatol. 2005;20 (11): 1641–1651.
  • Tong NK, Beran J, Kee SA, Immunogenicity and safety of an adjuvanted hepatitis B vaccine in pre-hemodialysis and hemodialysis patients. Kidney Int. 2005;68(5):2298–2303.
  • Yoon JW, Gollapudi S, Pahl MV, Vaziri ND. Naïve and central memory T-cell lymphopenia in end-stage renal disease. Kidney Int. 2006;70(2):371–376.
  • Agrawal S, Gollapudi P, Elahimehr R, Pahl MV, Vaziri ND. Effects of end-stage renal disease and hemodialysis on dendritic cell subsets and basal and LPS-stimulated cytokine production. Nephrol Dial Transplant. 2010;25(3):737–746.
  • Pahl MV, Gollapudi S, Sepassi L, Gollapudi P, Elahimehr R, Vaziri ND. Effect of end-stage renal disease on B-lymphocyte subpopulations, IL-7, BAFF and BAFF receptor expression. Nephrol Dial Transplant. 2010;25(1):205–212.
  • Chin AI. Hepatitis B virus vaccine response in hemodialysis baseline patient characteristics. Hemodial Int. 2003;7:296–303.
  • Thornton L, Fitzpatrick F, De La Harpe D, Hepatitis B reactivation in an Irish dialysis unit, 2005. Euro Surveill. 2007;12(4):E7–E8.
  • Centres for Disease Control and Prevention. Recommendations for preventing transmission of infections among chronic hemodialysis patients. MMWR Recomm Rep. 2001;50(RR-5):1–43.
  • Dentico P, Crovari P, Lai PL, Anamnestic response to administration of purified non-adsorbed hepatitis B surface antigen in healthy responders to hepatitis B vaccine with long-term non-protective antibody titers. Vaccine. 2002;20(31–32):3725–3730.
  • Fabrizi F, Martin P, Dixit V, Bunnapradist S, Dulai G. Meta-analysis: The effect of age on immunological response to hepatitis B vaccine in end-stage renal disease. Aliment Pharmacol Ther. 2004;20(10):1053–1062.
  • Lacson E, Teng M, Ong J, Vienneau L, Ofsthun N, Lazarus JM. Antibody response to Engerix-B and Recombivax-HB hepatitis B vaccination in end-stage renal disease. Hemodial Int. 2005;9(4):367–375.
  • Beran J. Safety and immunogenicity of a new hepatitis B vaccine for the protection of patients with renal insufficiency including pre-hemodialysis and hemodialysis patients. Expert Opin Biol Ther. 2008;8(2):235–247 (review).
  • Ocak S, Eskiocak AF. The evaluation of immune responses to hepatitis B vaccination in diabetic and non-diabetic hemodialysis patients and the use of tetanus toxoid. Nephrology (Carlton). 2008;13(6):487–491.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.